Interleukin-1β and Tumor Necrosis Factor-Α: Reliable Targets for Protective Therapies in Parkinson’s Disease?
Frontiers in Cellular Neuroscience - Switzerland
doi 10.3389/fncel.2013.00053
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Frontiers Media SA